Saving lives in congenital long QT syndrome: Who benefits from implantable cardioverter defibrillator therapy?

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 4, 2003, Pages 342-343

  Kaufman, Elizabeth S ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

DEFIBRILLATOR; EDITORIAL; GENE MUTATION; GENETIC DISORDER; HEART ARREST; HIGH RISK PATIENT; HUMAN; LONG QT SYNDROME; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; SYNCOPE;

DEFIBRILLATORS, IMPLANTABLE; HUMANS; LONG QT SYNDROME; RISK FACTORS;

EID: 0038298806     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2003.03069.x     Document Type: Editorial

References (12)

1. Schwartz PJ: Idiopathic long QT syndrome: Progress and questions. Am Heart J 1985;109:399-411.
2. Moss AJ, Robinson J: Clinical features of the idiopathic long QT syndrome. Circulation 1992;85(Suppl I):I-140-I-144.
3. Keating MT, Sanguinetti MC: Molecular genetic insights into cardiovascular disease. Science 1996;272:681-685.
4. Chiang CE, Roden DM: The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 2002;36:1-12.
5. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ, for the International Long-QT Syndrome Registry Research Group: Influence of the genotype on the clinical course of the long-QT syndrome. N Engl J Med 1998;339:960-965.
6. Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Zhiqing W: Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002;105:794-799.
7. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A, Robinson JL, Benhorin J, Choi S: The long QT syndrome: Prospective longitudinal study of 328 families. Circulation 1991;84:1136-1144.
8. Schwartz PJ, Locati E: The idiopathic long QT syndrome: Pathogenetic mechanisms and therapy. Eur Heart J 1985;6(Suppl D):103-114.
9. Dorostkar PC, Eldar M, Belhassen B, Scheinman MM: Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Circulation 1999;100:2431-2436.
10. Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML: Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000;101:616-623.
11. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M: Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003;14:337-341.
12. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J: Use of implantable cardioverter defibrillators in the congenital long QT syndrome. Am J Cardiol 1996;78:703-706.